J0896 Injection luspatercept-aamt 0.25mg
J-Codes
Also known as: Reblozyl, luspatercept, maturation agent
Luspatercept-aamt injection supplied in 0.25 milligram units, an erythroid maturation agent for treatment of anemia in myelodysplastic syndrome.
Clinical Context
Used for treatment of anemia in patients with lower-risk myelodysplastic syndrome requiring transfusion support.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.